← All investors
5AM Ventures
34 portfolio companies · 4 on the map · $210.4M raised · 4 cities
Portfolio map
4 5AM Ventures portfolio companies on the map.
Portfolio companies

Artiva Biotherapeutics
San Diego
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Biotechnology Research$198MEst. 2019
GlycoEra
Zurich
Advancing Glycan Mediated Therapy
Biotech$12.4MEst. 2020
MapLight Therapeutics
Redwood City
Maplight is a biopharmaceutical company that discovers and develops novel therapeutics for central nervous system disorders, with a focus on bringing new treatments to patients.
BiotechnologySeries DEst. 2018Impel Pharmaceuticals
Keller
Keller-based · pharmaceutical manufacturing.
Pharmaceutical ManufacturingEst. 2008
More portfolio companies
28 more 5AM Ventures investments we track beyond the map — 34 tracked in total.
CAMP4 TherapeuticsCambridge · Post-IPO Equity
Latigo BiotherapeuticsThousand Oaks · Series B
Precede BiosciencesBoston · Series B
Tyra BiosciencesCarlsbad · Post-IPO Equity
Wildcat Discovery TechnologiesSan Diego · Series C
Scientist.comSolana Beach · Series C
Spruce BiosciencesSouth San Francisco · Post-IPO Equity
Magnetic InsightAlameda · Series B
Carmot TherapeuticsBerkeley · Series E
ProLynxSan Francisco · Series A
RallybioFarmington · Series B
TMRW Life SciencesNew York · Series D
HalioHayward · Series D
Nvelop TherapeuticsCambridge · Seed
Skye BioscienceSan Diego · Post-IPO Equity
Radionetics OncologyCalifornia City · Series A
Precision NanoSystemVancouver · Series B
scPharmaceuticalsLexington · Series B
Escient PharmaceuticalsSan Diego · Series C
Bird Rock BioLa Jolla · Series B
Homology MedicinesLexington · Series B
NeurogastrxWoburn · Series B
Bellerophon TherapeuticsWarren · Series A
DVS SciencesSunnyvale · Series A
S*BIOSingapore · Venture
CalibriumCarmel · Convertible Note
Incline TherapeuticsRedwood City · Series A
VBI VaccinesCambridge · Series A
Portfolio map
4 5AM Ventures portfolio companies on the map.